Suven Life Science gains on acquiring Suven Pharmaceuticals

06 Feb 2019 Evaluate

Suven Life Sciences is currently trading at Rs. 206.10, up by 0.55 points or 0.27% from its previous closing of Rs. 205.55 on the BSE.

The scrip opened at Rs. 202.40 and has touched a high and low of Rs. 211.45 and Rs. 202.40 respectively. So far 28877 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 337.70 on 11-Sep-2018 and a 52 week low of Rs. 163.30 on 23-Mar-2018.

Last one week high and low of the scrip stood at Rs. 211.45 and Rs. 188.40 respectively. The current market cap of the company is Rs. 2616.29 crore.

The promoters holding in the company stood at 60.00%, while Institutions and Non-Institutions held 8.48% and 31.52% respectively.

Suven Life Science has acquired all the shares of Suven Pharmaceuticals (SPL), a public limited company, from its existing shareholders. Pursuant to which, Suven Pharmaceuticals has become a wholly owned subsidiary of the company. The board of directors at their meetings held on February 5, 2019 approved the same. The Board also approved draft Scheme of Arrangement to be filed at the National Company Law Tribunal bench at Hyderabad, for necessary approvals.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

Suven Life Sciences Share Price

170.15 -1.25 (-0.73%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×